S. Muoio & Co’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

S. Muoio & Co’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-280,384	Closed	-$1.06M	–	73
2020 Q1	$1.06M	Buy	+280,384	New	+$1.21M	1.38%	26

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $49.2B AUM 29.3% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

S. Muoio & Co's PGNX Position: Q2 2020 in Review

S. Muoio & Co sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 280,384 shares — an estimated $1.06M sold.

S. Muoio & Co first reported a position in PGNX in Q1 2020 and held it in 1 quarter. The position peaked at $1.06M in Q1 2020. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

S. Muoio & Co reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
S. Muoio & Co sold 280,384 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $1.06M.
S. Muoio & Co first reported a position in Progenics Pharmaceuticals Inc in Q1 2020 and held it in 1 quarter.
S. Muoio & Co's Progenics Pharmaceuticals Inc position peaked at $1.06M in Q1 2020.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on S. Muoio & Co's 13F filing for Q2 2020, filed 10 Aug 2020.